CSPC Pharmaceutical Group Limited (HK:1093)
:1093
Want to see HK:1093 full AI Analyst Report?
Total Valuation
CSPC Pharmaceutical Group has a market cap or net worth of HK$96.74B. The enterprise value is HK$89.42B.
Market CapHK$96.74B
Enterprise ValueHK$89.42B
Share Statistics
CSPC Pharmaceutical Group has 11,522,452,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,522,452,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CSPC Pharmaceutical Group’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 8.43%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)8.43%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee1.32M
Profits Per Employee196.74K
Employee Count21,400
Asset Turnover0.54
Inventory Turnover2.82
Valuation Ratios
The current PE Ratio of CSPC Pharmaceutical Group is 22.9. CSPC Pharmaceutical Group’s PEG ratio is -15.64.
PE Ratio22.9
PS Ratio3.41
PB Ratio2.61
Price to Fair Value2.61
Price to FCF21.69
Price to Operating Cash Flow14.62
PEG Ratio-15.64
Income Statement
In the last 12 months, CSPC Pharmaceutical Group had revenue of 28.20B and earned 4.21B in profits. Earnings per share was 0.37.
Revenue28.20B
Gross Profit18.50B
Operating Income4.31B
Pretax Income5.21B
Net Income4.21B
EBITDA5.84B
Earnings Per Share (EPS)0.37
Cash Flow
In the last 12 months, operating cash flow was 6.63B and capital expenditures -2.15B, giving a free cash flow of 4.48B billion.
Operating Cash Flow6.63B
Free Cash Flow4.48B
Free Cash Flow per Share0.39
Dividends & Yields
CSPC Pharmaceutical Group pays an annual dividend of HK$0.14, resulting in a dividend yield of 2.7%
Dividend Per ShareHK$0.14
Dividend Yield2.7%
Payout Ratio62.16%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.75
52-Week Price Change39.28%
50-Day Moving Average9.39
200-Day Moving Average9.05
Relative Strength Index (RSI)46.77
Average Volume (3m)135.86M
Important Dates
CSPC Pharmaceutical Group upcoming earnings date is Jun 3, 2026, TBA (Confirmed).
Last Earnings DateMar 25, 2026
Next Earnings DateJun 3, 2026
Ex-Dividend Date―
Financial Position
CSPC Pharmaceutical Group as a current ratio of 2.19, with Debt / Equity ratio of 1.93%
Current Ratio2.19
Quick Ratio1.88
Debt to Market Cap<0.01
Net Debt to EBITDA-1.04
Interest Coverage Ratio102.89
Taxes
In the past 12 months, CSPC Pharmaceutical Group has paid 1.01B in taxes.
Income Tax1.01B
Effective Tax Rate0.19
Enterprise Valuation
CSPC Pharmaceutical Group EV to EBITDA ratio is 15.46, with an EV/FCF ratio of 0.00.
EV to Sales3.20
EV to EBITDA15.46
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
CSPC Pharmaceutical Group has HK$9.87B in cash and marketable securities with HK$714.08M in debt, giving a net cash position of HK$9.16B billion.
Cash & Marketable SecuritiesHK$9.87B
Total DebtHK$714.08M
Net CashHK$9.16B
Net Cash Per ShareHK$0.80
Tangible Book Value Per ShareHK$3.08
Margins
Gross margin is 65.59%, with operating margin of 15.27%, and net profit margin of 14.93%.
Gross Margin65.59%
Operating Margin15.27%
Pretax Margin18.49%
Net Profit Margin14.93%
EBITDA Margin20.69%
EBIT Margin15.27%
Analyst Forecast
The average price target for CSPC Pharmaceutical Group is HK$11.30, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$11.30
Price Target Upside26.08% Upside
Analyst ConsensusModerate Buy
Analyst Count12
Revenue Growth Forecast-10.34%
EPS Growth Forecast-7.91%